Literature DB >> 10811389

Neural stem cells: from cell biology to cell replacement.

R J Armstrong1, C N Svendsen.   

Abstract

A large number of crippling neurological conditions result from the loss of certain cell populations from the nervous system through disease or injury, and these cells are not intrinsically replaced. Mounting evidence now suggests that replacement of depleted cell populations by transplantation may be of functional benefit in many such diseases. A diverse range of cell populations is vulnerable, and the loss of specific populations results in circumscribed deficits in different conditions. This diversity presents a considerable challenge if cell replacement therapy is to become widely applicable in the clinical domain, because each condition has specific requirements for the phenotype, developmental stage, and number of cells required. An ideal cell for universal application in cell replacement therapy would possess several key properties: it would be highly proliferative, allowing the ex vivo production of large numbers of cells from minimal donor material; it would also remain immature and phenotypically plastic such that it could differentiate into appropriate neural and glial cell types on, or prior to, transplantation. Critically, both proliferation and differentiation would be controllable. This review considers some of the evidence that stem cells exist in the central nervous system and that they may possess characteristics that make them ideal for broad application in cell replacement therapy.

Entities:  

Mesh:

Year:  2000        PMID: 10811389     DOI: 10.1177/096368970000900202

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  13 in total

1.  Direct isolation of human central nervous system stem cells.

Authors:  N Uchida; D W Buck; D He; M J Reitsma; M Masek; T V Phan; A S Tsukamoto; F H Gage; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Development and differentiation of multipotent human neural cells in vitro.

Authors:  R A Poltavtseva; M V Marei; I V Dubrovina; A V Revishchin; M A Aleksandrova; L I Korochkin; G T Sukhikh
Journal:  Dokl Biochem Biophys       Date:  2001 Jul-Aug       Impact factor: 0.788

Review 3.  Cell therapy in Huntington's disease.

Authors:  Stephen B Dunnett; Anne E Rosser
Journal:  NeuroRx       Date:  2004-10

Review 4.  The roles of hypoxia-inducible factors in regulating neural stem cells migration to glioma stem cells and determinating their fates.

Authors:  Suojun Zhang; Xiao Luo; Feng Wan; Ting Lei
Journal:  Neurochem Res       Date:  2012-09-19       Impact factor: 3.996

5.  Neural stem cell therapy of foetal onset hydrocephalus using the HTx rat as experimental model.

Authors:  Roberto Henzi; Karin Vío; Clara Jara; Conrad E Johanson; James P McAllister; Esteban M Rodríguez; Montserrat Guerra
Journal:  Cell Tissue Res       Date:  2020-02-17       Impact factor: 5.249

6.  Immunosuppressants affect human neural stem cells in vitro but not in an in vivo model of spinal cord injury.

Authors:  Christopher J Sontag; Hal X Nguyen; Noriko Kamei; Nobuko Uchida; Aileen J Anderson; Brian J Cummings
Journal:  Stem Cells Transl Med       Date:  2013-08-27       Impact factor: 6.940

7.  Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study.

Authors:  Alba I Rodriguez; Alison E Willing; Samuel Saporta; Don F Cameron; Paul R Sanberg
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

8.  Neurobehavioral assessment of transplanted porcine Sertoli cells into the intact rat striatum.

Authors:  Alba I Rodríguez; Alison E Willing; Don F Cameron; Samuel Saporta; Paul R Sandberg
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

Review 9.  The survival of neural precursor cell grafts is influenced by in vitro expansion.

Authors:  Rike Zietlow; Vladimir Pekarik; Richard J E Armstrong; Pamela Tyers; Stephen B Dunnett; Anne E Rosser
Journal:  J Anat       Date:  2005-09       Impact factor: 2.610

10.  Knockdown of BACE1-AS Nonprotein-Coding Transcript Modulates Beta-Amyloid-Related Hippocampal Neurogenesis.

Authors:  Farzaneh Modarresi; Mohammad Ali Faghihi; Nikunj S Patel; Barbara G Sahagan; Claes Wahlestedt; Miguel A Lopez-Toledano
Journal:  Int J Alzheimers Dis       Date:  2011-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.